Picture Berlin Partner BIO 2024 International Convention San Diego 650x100px

Person › Details

Bernard Coulie (ActoGenix N.V.)

Coulie, Bernard (Actogenix 201109 CEO + CMO)

	Organisation	ActoGenix N.V.
	Today	Precigen ActoBio (BE)
	Group	Precigen (Group)
	Product	ActoBiotics™ orally administered biopharmaceuticals
	Product 2	AG013 (Actogenix)

Record changed: 2024-01-19

Picture Berlin Partner BIO 2024 International Convention San Diego 650x200px

More documents for Bernard Coulie

[1] Calypso Biotech B.V.. (1/8/24). "Press Release: Calypso Enters into Agreement to Be Acquired by Novartis". Amsterdam....
[2] Dualyx N.V.. (5/15/23). "Press Release: Dualyx Raises €40 Million to Progress Treg Therapies for Autoimmune Diseases into the Clinic". Ghent....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]